TET1 and fragile X syndrome: To isolate the functional significance of DNA methylation in FXS, researchers have designed DNA methylation editing tools that exploit the fusion of a catalytically inactive Cas9 with the demethylating enzyme TET1 (dCas9-Tet1) to target methylation at a specific locus in the genome [70].